KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Short-term Investments: 2022-2025

Historic Short-term Investments for Castle Biosciences (CSTL) over the last 3 years, with Sep 2025 value amounting to $202.0 million.

  • Castle Biosciences' Short-term Investments rose 9.29% to $202.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $202.0 million, marking a year-over-year increase of 9.29%. This contributed to the annual value of $173.4 million for FY2024, which is 20.22% up from last year.
  • Per Castle Biosciences' latest filing, its Short-term Investments stood at $202.0 million for Q3 2025, which was up 4.28% from $193.7 million recorded in Q2 2025.
  • Over the past 5 years, Castle Biosciences' Short-term Investments peaked at $202.0 million during Q3 2025, and registered a low of $117.2 million during Q1 2023.
  • Over the past 3 years, Castle Biosciences' median Short-term Investments value was $173.4 million (recorded in 2024), while the average stood at $163.6 million.
  • Data for Castle Biosciences' Short-term Investments shows a peak YoY surged of 34.31% (in 2024) over the last 5 years.
  • Quarterly analysis of 4 years shows Castle Biosciences' Short-term Investments stood at $135.7 million in 2022, then increased by 6.32% to $144.3 million in 2023, then rose by 20.22% to $173.4 million in 2024, then rose by 9.29% to $202.0 million in 2025.
  • Its Short-term Investments was $202.0 million in Q3 2025, compared to $193.7 million in Q2 2025 and $185.5 million in Q1 2025.